Definitive Healthcare Corp. Class A Common Stock (DH) is a publicly traded Healthcare sector company. As of May 21, 2026, DH trades at $0.86 with a market cap of $88.70M and a P/E ratio of -0.53. DH moved -0.75% today. Year to date, DH is -65.07%; over the trailing twelve months it is -73.96%. Its 52-week range spans $0.81 to $5.68. Analyst consensus is neutral with an average price target of $2.51. Rallies surfaces DH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Definitive Healthcare Q4 Revenue Flat, Services Surge 49%, 29% EBITDA Margin: Definitive Healthcare’s Q4 revenue of $61.5 million slipped 1% year-over-year while professional services revenue surged 49%, offsetting a 3% subscription decline (7% ex-partnerships). Adjusted EBITDA reached $18.1 million (29% margin) and 2026 revenue guidance of $220–$226 million implies a 6–9% decline with 24–26% margin.
| Metric | Value |
|---|---|
| Price | $0.86 |
| Market Cap | $88.70M |
| P/E Ratio | -0.53 |
| EPS | $-1.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.68 |
| 52-Week Low | $0.81 |
| Volume | 460 |
| Avg Volume | 0 |
| Revenue (TTM) | $238.26M |
| Net Income | $-236.56M |
| Gross Margin | 76.04% |
10 analysts cover DH: 0 strong buy, 3 buy, 6 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.51.